Participants of BrightGene Bio-Medical Technology's (SHA:688166) phase 3 clinical trial lost weight and reduced their waistlines during the study, according to a Wednesday disclosure to the Shanghai bourse.
The company said the BGM0504 weight loss injection met primary and secondary endpoints during the trial.
Blood pressure among participants, who were either overweight or obese, also improved, the filing said.
Ley Choon's (SGX:Q0X) subsidiary, Ley Choon Constructions and Engineering, secured underground utilities services contracts worth SG$35.6 million, according to a Tuesday filing with the Singapore Exchange.Shares of the underground infrastructure services company were up nearly 3% in Wednesday trading.The contracts are expected to conclude within 24 to 36 months.
Goldwind Science & Technology (SHE:002202, HKG:2208) agreed to provide long-term operation and maintenance services for wind turbines in Morocco for a total guarantee amount of up to $29.4 million, according to a Shenzhen bourse filing on Wednesday.The deal was signed with Energie Eolienne du Maroc through a subsidiary, Goldwind Morocco (SARL).The Chinese wind power company's Hong Kong shares dropped 3%, while Shenzhen shares rose less than 3% during morning trade.
AusQuest (ASX:AQD) said reverse circulation drilling continues to define a continuous mineralized corridor extending more than 1,500 meters in length at the Cangallo porphyry copper-gold project in Peru, according to a Wednesday Australian bourse filing.Drilling encountered intercepts of 269 meters at 0.3% grade of copper and 0.1 grams per tonne (g/t) grade of gold from 160 meters, as well as 214 meters at 0.3% grade of copper and 0.1 g/t grade of gold from 124 meters.The company said that permitting of the stage four drill pads was prioritized to enable further drilling in the highly prospective southern portion of the prospect.